Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Beth Jacobs

Board of Governors

Managing Partner of Excellentia Global Partners

Beth Jacobs currently serves as Managing Partner of Excellentia Global Partners, a global life sciences investment bank, founded in 2008. Excellentia Global Partners works closely with early stage biotech and medical device companies, raising capital and enabling critical licensing and partnering with Big Pharma companies. Prior to establishing Excellentia Global Partners, Beth was a General Partner at Bio-IB, a life science-focused investment bank in New York.

Beth has served in senior executive roles in her twenty five years of experience in both investment banking and in the corporate sector. Prior to 2003, Beth served as Senior Vice President for Laureate Education (NASDAQ: LAUR), a $3 billion market cap company in the education sector.  She worked across all business units in a corporate development role, with a distinct focus on identifying and executing on opportunities in China.

Beth was Managing Director and Co-Head of Global Capital Markets at ING Barings, shortly after their acquisition of Furman Selz LLC, where she founded and led its international institutional equity group for over 9 years. She started her career at Prudential Securities where she founded the international institutional equity business, and later headed the same product execution group at both Morgan Stanley and Lehman Brothers.

She currently serves on the Board of Directors of EF Foundation, a global educational services company based in Stockholm and Cambridge, Mass, the Supervisory Board of Genomic Vision (GV listed on Euronext Exchange / Paris in DNA analysis), founding Global Ambassador for Susan G. Komen for the Cure, Board member for the Harvard Kennedy School of Government Women’s Leadership Board, Director of the William J. von Liebig Foundation. Previously, Beth served for 7 years as the Vice Chairman of the Friends of the Budapest Festival Orchestra.

Beth received an MBA in international finance from American University in Washington, DC in conjunction with the School of Foreign Service, and a BA, cum laude, from Boston College.  She also studied at Centre d’Etudes Internationale in Geneva, Switzerland. Beth is fluent in French.